We are live on ! Find out more
MSS

Mitchell Sinkler & Starr Portfolio holdings

AUM $240M
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+9.9%
1 Year Est. Return
+24.63%
3 Year Est. Return
+72.22%
5 Year Est. Return
+87.27%
10 Year Est. Return
+266.58%
AUM
$550M
AUM Growth
+$225M
Cap. Flow
+$184M
Cap. Flow %
33.48%
Top 10 Hldgs %
33.98%
Holding
204
New
99
Increased
93
Reduced
4
Closed
2

Top Sells

Rank Stock Value
1
MCO icon
Moody's
MCO
+$334K
2
BDX icon
Becton Dickinson
BDX
+$241K
3
GPN icon
Global Payments
GPN
+$229K
4
ADM icon
Archer Daniels Midland
ADM
+$65.9K
5
GLW icon
Corning
GLW
+$57.2K

Sector Composition

Rank Sector Weight
1 Technology 20.18%
2 Healthcare 17.96%
3 Consumer Staples 9.31%
4 Financials 9.09%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHW
101
Charles Schwab
SCHW
$177B
$893K 0.16%
12,986
+1,380
+12% +$79.7K
SPGI icon
102
S&P Global
SPGI
$126B
$885K 0.16%
2,009
+560
+39% +$221K
MO icon
103
Altria Group
MO
$122B
$866K 0.16%
21,478
+2,676
+14% +$111K
SCHX icon
104
Schwab US Large- Cap ETF
SCHX
$70.9B
$854K 0.16%
+45,438
New +$798K
AMGN icon
105
Amgen
AMGN
$203B
$837K 0.15%
2,905
+600
+26% +$163K
IGIB icon
106
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.3B
$789K 0.14%
+15,171
New +$750K
AJG icon
107
Arthur J. Gallagher & Co
AJG
$63.7B
$787K 0.14%
3,500
-50
-1% -$11.8K
GNRC icon
108
Generac Holdings
GNRC
$11.9B
$787K 0.14%
6,087
+2,250
+59% +$247K
NVS icon
109
Novartis
NVS
$295B
$780K 0.14%
7,728
+3,420
+79% +$330K
LMT icon
110
Lockheed Martin
LMT
$134B
$780K 0.14%
1,720
+583
+51% +$258K
PRU icon
111
Prudential Financial
PRU
$41.7B
$774K 0.14%
7,464
+1,700
+29% +$163K
IVV icon
112
iShares Core S&P 500 ETF
IVV
$876B
$768K 0.14%
+1,608
New +$720K
DCI icon
113
Donaldson
DCI
$10.8B
$738K 0.13%
+11,300
New +$689K
UNH icon
114
UnitedHealth
UNH
$382B
$733K 0.13%
1,392
+150
+12% +$80K
EXPD icon
115
Expeditors International
EXPD
$22.9B
$724K 0.13%
5,691
+1,840
+48% +$217K
XBI icon
116
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$672K 0.12%
+7,525
New +$559K
BHB icon
117
Bar Harbor Bankshares
BHB
$654M
$668K 0.12%
+22,750
New +$596K
KNSL icon
118
Kinsale Capital Group
KNSL
$7.95B
$666K 0.12%
1,990
+790
+66% +$293K
ORI icon
119
Old Republic International
ORI
$10.3B
$659K 0.12%
+22,400
New +$630K
ADBE icon
120
Adobe
ADBE
$89.5B
$623K 0.11%
+1,044
New +$602K
BCE icon
121
BCE
BCE
$19.9B
$623K 0.11%
+15,808
New +$612K
PARA
122
DELISTED
Paramount Global Class B
PARA
$617K 0.11%
41,699
CASY icon
123
Casey's General Stores
CASY
$31.9B
$606K 0.11%
2,205
+690
+46% +$189K
PNC icon
124
PNC Financial Services
PNC
$100B
$583K 0.11%
+3,764
New +$487K
GEHC icon
125
GE HealthCare
GEHC
$27.6B
$569K 0.1%
7,361
+2,716
+58% +$190K

Similar funds

Mitchell Sinkler & Starr's Q4 2023 Portfolio in Review

As of Q4 2023, Mitchell Sinkler & Starr held 204 positions worth $550M, up 69% from $325M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Mitchell Sinkler & Starr deployed $184M of net new capital in Q4 2023, opening 99 new positions and adding to 93 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 36,356 shares worth $9.53M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Moody's, an estimated $334K trimmed.

  • Mitchell Sinkler & Starr's largest Q4 2023 buy was iShares Russell 1000 ETF: 36,356 shares worth $9.53M.
  • Mitchell Sinkler & Starr added most to Microsoft in Q4 2023, an estimated $6.91M increase.
  • Mitchell Sinkler & Starr's biggest Q4 2023 reduction was Moody's, cutting an estimated $334K.
  • Mitchell Sinkler & Starr fully exited Becton Dickinson in Q4 2023, selling an estimated $241K.
  • Mitchell Sinkler & Starr's ten largest holdings make up 34% of its $550M portfolio in Q4 2023.
  • Mitchell Sinkler & Starr opened 99 new positions and closed 2 in Q4 2023.
  • Mitchell Sinkler & Starr's portfolio value rose 69% quarter-over-quarter to $550M.

Based on Mitchell Sinkler & Starr's 13F filing for Q4 2023, filed 12 Feb 2024.